Tisagenlecleucel and Lisocabtagene Maraleucel: Comparative Efficacy in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

被引：0
|
作者：
Schuster, Stephen J. [1 ]
Zhang, Jie [2 ]
Yang, Hongbo [3 ]
Agarwal, Abhijit [2 ]
Tang, Wenxi [3 ]
Prieto, Marcela Martinez [2 ]
Bollu, Vamsi [2 ]
Kuzan, David [2 ]
Maziarz, Richard [4 ]
Kersten, Marie Jose [5 ]
机构：
[1] Univ Penn, Div Hematol & Oncol, Philadelphia, PA 19104 USA
[2] Novartis Pharmaceut, E Hanover, NJ USA
[3] Anal Grp Inc, Boston, MA USA
[4] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA
[5] Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷
关键词：
ABCL; diffuse large B-cell lymphoma; CAR-T cell therapy; MAIC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ABCL-166
引用
收藏
页码：S380 / S381
页数：2
相关论文
共 50 条
  • [41] y Portia: A Phase 1b Study Evaluating Safety and Efficacy of Tisagenlecleucel and Pembrolizumab in Patients with Relapsed/ Refractory Diffuse Large B-Cell Lymphoma
    Jaeger, Ulrich
    Worel, Nina
    McGuirk, Joseph P.
    Riedell, Peter A.
    Fleury, Isabelle
    Borchmann, Peter
    Chu, Jufen
    Abdelhady, Ahmed M.
    Forcina, Alessandra
    Pacaud, Lida Bubuteishvili
    Waller, Edmund K.
    BLOOD, 2019, 134
  • [42] Safety and Efficacy of a DNA Oligonucleotide Therapy in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Westin, Jason
    Maris, Michael B.
    Jacobson, Caron A.
    Patel, Prapti
    Lakhani, Nehal
    Harb, Wael
    Patel-Donnelly, Dipti
    McCaul, Kelly
    Escobar, Carolina
    Klencke, Barbara
    Al-Katib, Ayad M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (01): : 52 - 59
  • [43] Safety and Efficacy of Rituximab Plus Bendamustine in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients
    Arcari, Annalisa
    Chiappella, Annalisa
    Valenti, Vanessa
    Zanlari, Luca
    Tani, Monica
    Marasca, Roberto
    Cabras, Maria Giuseppina
    Spina, Michele
    Santagostino, Alberto
    Ilariucci, Fiorella
    Carli, Giuseppe
    Musto, Pellegrino
    Savini, Paolo
    Marino, Dario
    Ghio, Francesco
    Gentile, Massimo
    Cox, Maria Christina
    Della Seta, Roberta
    Vallisa, Daniele
    BLOOD, 2014, 124 (21)
  • [44] Efficacy and safety of lenalinomide combined with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma
    Ivanov, Vadim
    Coso, Diane
    Chetaille, Bruno
    Esterni, Benjamin
    Olive, Daniel
    Aurran-Schleinitz, Therese
    Schiano, Jean Marc
    Stoppa, Anne-Marie
    Broussais-Guillaumot, Florence
    Blaise, Didier
    Bouabdallah, Reda
    LEUKEMIA & LYMPHOMA, 2014, 55 (11) : 2508 - 2513
  • [45] Tisagenlecleucel in Diffuse Large B-Cell Lymphoma Reply
    Schuster, Stephen J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (16): : 1586 - 1586
  • [46] Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
    Abramson, Jeremy S.
    Palomba, M. Lia
    Gordon, Leo I.
    Lunning, Matthew A.
    Wang, Michael
    Arnason, Jon
    Mehta, Amitkumar
    Purev, Enkhtsetseg
    Maloney, David G.
    Andreadis, Charalambos
    Sehgal, Alison
    Solomon, Scott R.
    Ghosh, Nilanjan
    Albertson, Tina M.
    Garcia, Jacob
    Kostic, Ana
    Mallaney, Mary
    Ogasawara, Ken
    Newhall, Kathryn
    Kim, Yeonhee
    Li, Daniel
    Siddiqi, Tanya
    LANCET, 2020, 396 (10254): : 839 - 852
  • [47] Safety and Preliminary Efficacy in Patients With Relapsed/Refractory Mantle Cell Lymphoma Receiving Lisocabtagene Maraleucel in TRANSCEND NHL 001
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (04) : 10 - 11
  • [48] A COMPARATIVE ANALYSIS OF NATIONAL HEALTH TECHNOLOGY ASSESSMENTS OF TISAGENLECLEUCEL (KYMRIAH®) FOR RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA
    Mc Veigh, C.
    Treanor, R.
    Carey, N.
    VALUE IN HEALTH, 2020, 23 : S466 - S466
  • [49] COST-EFFECTIVENESS OF TISAGENLECLEUCEL FOR ADULTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA : A CANADIAN SOCIETAL PERSPECTIVE
    Yang, H.
    Qi, C.
    Zhang, J.
    El Ouagari, K.
    VALUE IN HEALTH, 2018, 21 : S44 - S44
  • [50] Safety and Preliminary Efficacy in Patients with Relapsed/Refractory Mantle Cell Lymphoma Receiving Lisocabtagene Maraleucel in Transcend NHL 001
    Palomba, Maria Lia
    Gordon, Leo I.
    Siddiqi, Tanya
    Abramson, Jeremy S.
    Kamdar, Manali
    Lunning, Matthew A.
    Maloney, David G.
    Andreadis, Charalambos
    Arnason, Jon E.
    Ghosh, Nilanjan
    Mehta, Amitkumar
    Solomon, Scott R.
    Farazi, Thalia
    Garcia, Jacob
    Dehner, Christine
    Ogasawara, Ken
    Gao, Jie
    Wang, Michael
    BLOOD, 2020, 136
12345